BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27208796)

  • 21. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
    Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
    Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes.
    Hirai M; Ono K; Morimoto T; Kawamura T; Wada H; Kita T; Hasegawa K
    J Biol Chem; 2004 Sep; 279(36):37640-50. PubMed ID: 15220332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.
    Katanasaka Y; Sunagawa Y; Hasegawa K; Morimoto T
    Biol Pharm Bull; 2013; 36(1):13-7. PubMed ID: 23302632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.
    Li Q; Shen P; Zeng S; Liu P
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):196-203. PubMed ID: 26252173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac p300 is involved in myocyte growth with decompensated heart failure.
    Yanazume T; Hasegawa K; Morimoto T; Kawamura T; Wada H; Matsumori A; Kawase Y; Hirai M; Kita T
    Mol Cell Biol; 2003 May; 23(10):3593-606. PubMed ID: 12724418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo.
    van Berlo JH; Elrod JW; Aronow BJ; Pu WT; Molkentin JD
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12331-6. PubMed ID: 21746915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
    Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
    J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
    Duan Y; Zhou B; Su H; Liu Y; Du C
    Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
    Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
    PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis.
    He-nan Z; Yan W; Miao-na J; Cai-hua Z; Shen L; Yu-jie J
    Pathol Res Pract; 2009; 205(9):615-25. PubMed ID: 19327894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kindlin-2 suppresses transcription factor GATA4 through interaction with SUV39H1 to attenuate hypertrophy.
    Qi L; Chi X; Zhang X; Feng X; Chu W; Zhang S; Wu J; Song Y; Zhang Y; Kong W; Yu Y; Zhang H
    Cell Death Dis; 2019 Nov; 10(12):890. PubMed ID: 31767831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.
    Hirotani S; Higuchi Y; Nishida K; Nakayama H; Yamaguchi O; Hikoso S; Takeda T; Kashiwase K; Watanabe T; Asahi M; Taniike M; Tsujimoto I; Matsumura Y; Sasaki T; Hori M; Otsu K
    J Mol Cell Cardiol; 2004 Jun; 36(6):799-807. PubMed ID: 15158121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X; Zhang L; Liang J
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
    Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
    Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.
    Wei JQ; Shehadeh LA; Mitrani JM; Pessanha M; Slepak TI; Webster KA; Bishopric NH
    Circulation; 2008 Aug; 118(9):934-46. PubMed ID: 18697823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
    Liu Y; Wang Z; Xiao W
    Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin-activated ERK/MAP kinase enhances GATA-4 acetylation via phosphorylation of serine 261 of GATA-4.
    Jun JH; Shim JK; Ryoo HM; Kwak YL
    J Cell Physiol; 2013 Jan; 228(1):190-7. PubMed ID: 22674427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.